✦ LIBER ✦

Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib

✍ Scribed by Theognosia Vergou; Alexander J. Stratigos; Eleni M. Karapanagiotou; Athina E. Matekovits; Kalliopi D. Dilana; Sotirios Tsimboukis; Christina Antoniou; Vassiliki Chasapi; Kostas N. Syrigos

Book ID: 116586527
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 525 KB
Volume: 63
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2009.11.589

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Follicular and epidermal alterations in

Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor

✍ R. Van Doorn; G. Kirtschig; E. Scheffer; T.J. Stoof; G. Giaccone 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

We report the cutaneous side-effects of ZD1839 (Iressa), a new anticancer agent that acts by inhibiting epidermal growth factor (EGF) receptor signal transduction. Three patients receiving ZD1839 developed an eruption consisting of follicular papules and pustules in an acneiform distribution as well

A case report of inflammatory nonscarrin

A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib

✍ Marinya Pongpudpunth; Marie France Demierre; Lynne J. Goldberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

Refractory aggressive keratoacanthoma ce

Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with the epidermal growth factor receptor inhibitor erlotinib

✍ T.K. Bulj; A.L. Krunic; A.S. Cetner; J.L. Villano 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 1020 KB

Epidermal Growth Factor Receptor Inhibit

Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma

✍ Heather DeGrendele; Chandra P. Belani; Michael C. Perry 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 88 KB

Interstitial lung disease in patients wi

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

✍ Masahiro Tsuboi; Thierry Le Chevalier 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 111 KB

Epidermal growth factor receptor polymor

Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib

✍ Trevor McKibbin; Wei Zhao; Michael Tagen; Najat C. Daw; Wayne L. Furman; Lisa M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 155 KB